Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

1.9K
The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
1.9K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups

30.3K

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
30.3K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
SN1 Reaction: Stereochemistry02:15

SN1 Reaction: Stereochemistry

10.4K
This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Metal-Organic Framework-Biopolymer-Based Hydrogels for Therapeutic Delivery.

ACS materials Au·2026
Same author

Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogens.

RSC chemical biology·2026
Same author

Nanoscale Biodegradable Printing for Designed Tuneability of Vaccine Delivery Kinetics.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice.

Vaccines·2024
Same author

Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk.

Nature communications·2024
Same author

Omicron breakthrough infections in vaccinated or previously infected hamsters.

Proceedings of the National Academy of Sciences of the United States of America·2023

Related Experiment Video

Updated: Feb 12, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K

Advances in HIV-1 Vaccine Development.

Yong Gao1, Paul F McKay2, Jamie F S Mann3

  • 1Department of Microbiology and Immunology, University of Western Ontario, London, ON, N6A 5C1, Canada. ygao387@uwo.ca.

Viruses
|April 5, 2018
PubMed
Summary

Developing an effective human immunodeficiency virus type 1 (HIV-1) vaccine is crucial. While the RV144 trial showed modest protection, ongoing research explores new technologies and immune correlates to advance HIV vaccine development.

Keywords:
HIV-1antibodiesimmunogenneutralizationvaccine

More Related Videos

In vitro Uncoating of HIV-1 Cores
10:49

In vitro Uncoating of HIV-1 Cores

Published on: November 8, 2011

16.3K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.8K

Related Experiment Videos

Last Updated: Feb 12, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K
In vitro Uncoating of HIV-1 Cores
10:49

In vitro Uncoating of HIV-1 Cores

Published on: November 8, 2011

16.3K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.8K

Area of Science:

  • * Vaccinology and immunology research focused on preventing viral infections.
  • * Development of novel vaccine strategies and immunogen design for infectious diseases.

Background:

  • * An effective human immunodeficiency virus type 1 (HIV-1) vaccine remains a critical goal to control the global epidemic.
  • * Despite extensive research, only the RV144 trial has demonstrated limited efficacy in preventing HIV-1 acquisition.

Purpose of the Study:

  • * To review the historical progression of HIV vaccine development efforts.
  • * To discuss emerging technologies and innovative immunogen designs in HIV vaccinology.
  • * To highlight ongoing studies investigating vaccine-induced immune correlates of protection against HIV-1.

Main Methods:

  • * Literature review of historical HIV vaccine trials and development milestones.
  • * Analysis of current research trends in vaccinology, including novel technology platforms.
  • * Examination of studies focusing on immunogen design and immune correlates of protection.

Main Results:

  • * The RV144 trial represents the sole instance of a vaccine conferring partial protection against HIV-1 acquisition.
  • * Significant advancements in understanding immune responses and developing new vaccine candidates are underway.
  • * Identifying reliable immune correlates of protection is essential for future vaccine efficacy.

Conclusions:

  • * Continued innovation in vaccine technology and immunogen design is vital for developing an efficacious HIV-1 vaccine.
  • * Further research into immune correlates of protection is necessary to guide future clinical trials and vaccine development.
  • * The pursuit of an effective HIV-1 vaccine remains a priority in global public health efforts.